Navigation Links
UCI receives prestigious federal research award to hasten medical advances
Date:7/14/2010

Irvine, Calif., July 14, 2010 The Institute for Clinical & Translational Science at UC Irvine will get $20 million over five years from the National Institutes of Health to speed the transformation of scientific discoveries into medical advances for patients.

UCI is the first medical research institution in Orange County and the eighth statewide to receive the competitive Clinical & Translational Science Award. It enters a prestigious national consortium of CTSA beneficiaries whose membership will be capped at 60 by 2012. The NIH announced nine awardees today.

The sixth-largest grant in UCI history, the CTSA will foster multidisciplinary research involving the community in a wide range of fields such as genetics, diabetes, gerontology, pediatrics, cancer and infectious diseases while funding efforts to overcome impediments to biomedical innovation.

"With this award, UCI joins a select group of institutions supported by NIH to forge a new direction for clinical research in the U.S. for a generation to come," said Dr. Dan Cooper, ICTS director and primary CTSA investigator. "The grant will jump-start our endeavors to build effective multidisciplinary research teams to tackle important health issues, and it will bolster efforts to involve our community in the excitement of clinical discovery as partners."

Specifically, he said, the CTSA will support:

  • Development of novel technologies, such as devices that can detect diseases like diabetes in exhaled breath.
  • Innovative pilot studies, such as one for the early identification of cerebral palsy in babies.
  • Successful navigation of regulatory barriers to clinical studies.
  • Research into biostatistics, study design and bioethics.
  • Vigorous efforts to involve community partners in a meaningful way with new research projects particularly relevant to Southern California residents.
  • Creation of outstanding research facilities and the hiring of research nursing and study coordinators for UCI translational scientists.
  • Training of the next generation of clinical scientists through certificate and master's programs in clinical research.

"A critical goal of biomedical research is to transform discoveries into preventions, treatments and cures," said NIH director Dr. Francis S. Collins. "By working together, CTSA institutions are removing barriers to research, training new generations of clinical and laboratory research teams, and providing them with the equipment and resources they need."

Founded in 2006, the ICTS is the lynchpin of UCI's clinical research efforts. Housed at UC Irvine Medical Center, it encompasses hundreds of studies by faculty and staff members.

"Our expectation is that with the CTSA's considerable support, the ICTS will generate new knowledge of immediate and long-term importance to the healthcare of people everywhere," Cooper said. "The ICTS will inspire the next generation of healthcare professionals to focus on the possibilities of medicine and turn these ideas into reality."


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. Innovotech receives funding to advance environmentally friendly agricultural crop protection product
2. Dr. Jayne Fulkerson receives $3.2 million NIH grant
3. University receives $19 million to monitor carbon storage project
4. UCLAs James Liao receives Presidential Green Chemistry Challenge Award from EPA
5. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
6. Neuroscientist Robert H. Wurtz receives the $500,000 Gruber neuroscience prize
7. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
8. Norwegian Institute of Public Health receives $100,000 Grand Challenges Explorations grant
9. HJF research psychologist receives Sleep Research Societys Young Investigator Award
10. VIB-UGent scientist Jiri Friml receives Koerber European Science Award 2010
11. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: